OpenVSafe by OpenVAERS
Search V-safe

5SF-13376-11756

4 vaccinations 7 coded responses 24 check-ins 6 free-text entries 3 call cases
Sex
Male
Age at first dose
56-60
ZIP prefix
410 / KY
Registered
2021-01-28
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-28
    Registered in v-safe
  2. 2021-01-28
    Dose 1 — Moderna
  3. 2021-01-28
    Health check-in — day 0, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  4. 2021-01-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Abdominal pain
    Adult check-in
  7. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-19
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-25
    Dose 2 — Moderna
  12. 2021-02-25
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  15. 2021-03-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  16. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-18
    Survey response — day 21, dose 2
    MedDRA: Blood pressure increased, Depression, Heart rate increased — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Medication related changes to blood pressure and heart rate. Increased depression.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-18
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-03-29
    Survey response — day 28, dose 2
    MedDRA: Cough, Headache — Feeling: Fair
    Free text: Persistent cough and headaches.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-27
    Survey response — 3 months, dose 2
    MedDRA: Hypersensitivity, Respiratory disorder, Sinus disorder — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Allergy related upper respiratorysinuses, eyes primarily. Also am having to have a root canal, tooth no. 3.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-05-27
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-08-26
    Survey response — 6 months, dose 2
    MedDRA: Clostridium difficile infection, Cough, Diarrhoea, Vomiting — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: vomiting, diarrhea, persistent cough, and was diagnosed with c. diff.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-08-26
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-08-27
  28. 2021-08-27
  29. 2021-08-27
  30. 2021-09-16
    Call successful
    Reported to VAERS during previous contact from GDIT
  31. 2021-09-16
    Call successful
    Reported to VAERS during previous contact from GDIT
  32. 2021-09-16
    Call successful
    Reported to VAERS during previous contact from GDIT
  33. 2021-11-29
    Dose 3 — Moderna
  34. 2022-03-02
    Survey response — 12 months, dose 2
    MedDRA: Inflammation — Feeling: Good
    Free text: General inflammatory symptoms, probably relative to diet and/or medication change.
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-05-30
    Survey response — 6 months, dose 3
    MedDRA: Ageusia, Cough, Headache, Listless, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Cough, headaches, listlessness, loss of taste, sore throat.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-07-12
    Dose 4 — Moderna
  37. 2022-10-11
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  38. 2023-01-10
    Survey response — 6 months, dose 4
    MedDRA: Cough, Diarrhoea, Influenza like illness, Nausea, Oropharyngeal pain, Pyrexia, Respiratory tract congestion, Sinusitis — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Moderna
22021-02-25Moderna
32021-11-29Moderna No
42022-07-12Moderna No

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 3

2 waits over 3 months for a first call

See the call center timeline

Free text

Release 5 — day 21, dose 2

2021-03-18

Symptoms: Medication related changes to blood pressure and heart rate. Increased depression.

Release 6 — day 28, dose 2

2021-03-29

Symptoms: Persistent cough and headaches.

Release 8 — 3 months, dose 2

2021-05-27

Symptoms: Allergy related upper respiratorysinuses, eyes primarily. Also am having to have a root canal, tooth no. 3.

Release 9 — 6 months, dose 2

2021-08-26

Symptoms: vomiting, diarrhea, persistent cough, and was diagnosed with c. diff.

Release 11 — 12 months, dose 2

2022-03-02

Symptoms: General inflammatory symptoms, probably relative to diet and/or medication change.

Release 11 — 6 months, dose 3

2022-05-30

Symptoms: Cough, headaches, listlessness, loss of taste, sore throat.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDBlood pressure increased ✓ ✓ ✓
SDClostridium difficile infection ✓ · ✓
SDCough ✓ ✓ ✓
SDDepression ✓ ✓ ✓
SDDiarrhoea ✓ · ✓
SDHeadache ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDHypersensitivity ✓ ✓ ✓
SDInflammation · · ✓
SDInfluenza like illness · · ✓
SDListless · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDPyrexia · · ✓
SDRespiratory disorder ✓ ✓ ✓
SDRespiratory tract congestion · · ✓
SDSinus disorder ✓ ✓ ✓
SDSinusitis · · ✓
SDVomiting ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release